Literature DB >> 2419258

Augmentation of human polymorphonuclear leukocyte adherence by interferon.

W K Seow, Y H Thong.   

Abstract

Augmentation of human polymorphonuclear leucocyte adherence by alpha and gamma interferons occurred as early as 2 min after incubation. Enhancement of adherence occurred at optimal concentrations of 100-1,000 IU/ml. There was synergism between alpha and gamma interferons, but not between two subtypes of alpha interferon, on augmentation of adherence, indicating that alpha and gamma interferons act on different receptors on the polymorphonuclear leucocyte. Heat treatment at 65 degrees C for 30 min abolished the effect of interferon on adherence.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419258     DOI: 10.1159/000233991

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

1.  Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon-gamma.

Authors:  I C Kowanko; A Ferrante
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

Review 2.  Interferon-gamma activation of polymorphonuclear neutrophil function.

Authors:  Terri N Ellis; Blaine L Beaman
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

3.  Macrophage-neutrophil interactions: contrasting effects of the monokines interleukin-1 and tumour necrosis factor (cachectin) on human neutrophil adherence.

Authors:  W K Seow; Y H Thong; A Ferrante
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

4.  Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release.

Authors:  A Ferrante
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Antiviral and antigenic properties of recombinant porcine interferon gamma.

Authors:  B Charley; K McCullough; S Martinod
Journal:  Vet Immunol Immunopathol       Date:  1988-09       Impact factor: 2.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.